Tuesday, September 13, 2016

BRIEF-Regenxbio publishes data from ongoing preclinical studies of NAV gene therapy in Neurodegenerative diseases

* Regenxbio publishes data from ongoing preclinical studies

of NAV gene therapy in neurodegenerative diseases

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)